Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factor”

2,294 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,294 results

Not applicableStudy completedNCT01465399
What this trial is testing

Plasma Rich in Growth Factors (PRGF-Endoret) in the Regeneration of Post-Extraction Sockets

Who this might be right for
Post-Extraction Sockets Healing
Fundación Eduardo Anitua 60
Early research (Phase 1)Study completedNCT01392521
What this trial is testing

Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Protein Kinase) Inhibitor Refametinib (BAY86-9766) in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Bayer 64
Early research (Phase 1)Active Not RecruitingNCT04141644
What this trial is testing

Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC

Who this might be right for
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)
University of Utah 24
Not applicableNot Yet RecruitingNCT06338644
What this trial is testing

Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients.

Who this might be right for
Hormone-receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastMetastatic Breast Cancer
Helwan University 100
Not applicableStudy completedNCT05542381
What this trial is testing

The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

Who this might be right for
Age-Related Macular Degeneration
Virginia Polytechnic Institute and State University 64
Testing effectiveness (Phase 2)Study completedNCT00193063
What this trial is testing

Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 41
Not applicableStudy completedNCT02285361
What this trial is testing

GIOTRIF rPMS in Korean Patients With NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 1,272
Early research (Phase 1)Study completedNCT01976169
What this trial is testing

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)

Who this might be right for
Advanced Breast Cancer
University of Texas Southwestern Medical Center 29
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319
What this trial is testing

A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Large-scale testing (Phase 3)Study completedNCT01436864
What this trial is testing

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 125
Not applicableStudy completedNCT02777658
What this trial is testing

PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 169
Testing effectiveness (Phase 2)Looking for participantsNCT07049926
What this trial is testing

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 140
Post-approval studies (Phase 4)Study completedNCT02514174
What this trial is testing

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Who this might be right for
Carcinoma, Non-Small-Cell LungErbB Receptors
Boehringer Ingelheim 25
Testing effectiveness (Phase 2)Looking for participantsNCT06841055
What this trial is testing

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

Who this might be right for
Non-small Cell Lung Cancer
BioNTech SE 60
Not applicableStudy completedNCT03413176
What this trial is testing

Evaluation of Reporting of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors Associated Cardiovascular Adverse reactioN.

Who this might be right for
Cardiac ComplicationVascular Diseases
Groupe Hospitalier Pitie-Salpetriere 150,000
Large-scale testing (Phase 3)Study completedNCT01217476
What this trial is testing

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study

Who this might be right for
Diabetic Foot Ulcer of Neuropathic Origin
Olympus Biotech Corporation 207
Not applicableStudy completedNCT07199868
What this trial is testing

The Role of Ovarian PRP Therapy in Poseidon Poor Responders Women Undergoing ICSI Cycle

Who this might be right for
Poor Ovarian ReservePlatelet Derived Growth Factor
Karbala University 102
Early research (Phase 1)Active Not RecruitingNCT04167540
What this trial is testing

GDNF Gene Therapy for Parkinson's Disease

Who this might be right for
Parkinson's Disease
Brain Neurotherapy Bio, Inc. 11
Not applicableStudy completedNCT01235260
What this trial is testing

Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes

Who this might be right for
Diabetes MellitusFoot UlcerDiabetic Foot+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Testing effectiveness (Phase 2)Study completedNCT00580333
What this trial is testing

Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

Who this might be right for
Breast Cancer
Massachusetts General Hospital 51
Load More Results